根据名称进行药物检索
Nifedical XL与肾功能不全
Nifedical XL与肾功能不全安全配伍检测的结果。
检测结果:
Nifedical XL <> 肾功能不全
现实性: 23.07.2019
评论家: 医学副博士Shkutko P.M., in
通过权威的信息来源 Drugs.com、Rxlist.com、Webmd.com、Medscape.com,在进行所选药物与这种伴发疾病互相作用检测时,发现一些会产生负面影响或对身体危害的禁忌症及副作用。
用户:虽然清除硝苯地平是不依赖于肾功能,使用该药物的患者的尿毒症已经与增强的药理效果,可能是由于增加灵敏的药品,或减少蛋白质结合。 很少的、可逆的海拔在髻和血清肌酸酐已报告在患有先前存在的慢性肾功能不全给予硝苯地平,虽然因果关系尚未建立。 肾炎和肾功能衰竭也已观察到的。 治疗与硝苯地平应给予谨慎的患者显着损害肾功能。
来源
- Zucchelli P, Zuccala A, Borghi M, et al "Long-term comparison between captopril and nifedipine in the progression of renal insufficiency." Kidney Int 42 (1992): 452-8
- Cacoub P, Deray JY, Deray G, et al "Nifedipine-induced acute renal failure." Clin Nephrol 29 (1988): 272-3
- van Bortel L, Bohm R, Mooij J, et al "Total and free steady-state plasma levels and pharmacokinetics of nifedipine in patients with terminal renal failure." Eur J Clin Pharmacol 37 (1989): 185-9
- Kleinbloesem CH, van Brummelen P, van Harten J, et al "Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship." Clin Pharmacol Ther 37 (1985): 563-74
- Diamond JR, Cheung JY, Fang LS "Nifedipine-induced renal dysfunction." Am J Med 77 (1984): 905-9
- Diamond JR, Cheung JY, Fang LST "Nifedipine-induced renal dysfunction." Am J Med 77 (1984): 905-9
- "Product Information. Procardia (nifedipine)." Pfizer US Pharmaceuticals, New York, NY.
- Robertson DR, Waller DG, Renwick AG, George CF "Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine." Br J Clin Pharmacol 25 (1988): 297-305
- Ene MD, Roberts CJ "Pharmacokinetics of nifedipine after oral administration in chronic liver disease." J Clin Pharmacol 27 (1987): 1001-4
- Kates RE "Calcium antagonists: pharmacokinetic properties." Drugs 25 (1983): 113-24
- Scoble JE, Uff JS, Eastwood B "Nifedipine nephritis." Clin Nephrol 21 (1984): 302
- Echizen H, Eichelbaum M "Clinical pharmacokinetics of verapamil, nifedipine and diltiazem." Clin Pharmacokinet 11 (1986): 425-49
- Eicher JC, Morelon P, Chalopin JM, et al "Acute renal failure during nifedipine therapy in a patient with congestive heart failure." Crit Care Med 16 (1988): 1163-4
- McAllister RG Jr, Hamann SR, Blouin RA "Pharmacokinetics of calcium-entry blockers." Am J Cardiol 55 (1985): b30-40
- Pahor M, Manto A, Pedone C, Carosella L, Guralnik JM, Carbonin P "Age and severe adverse drug reactions caused by nifedipine and verapamil." J Clin Epidemiol 49 (1996): 921-8
- "Product Information. Adalat (nifedipine)." Bayer, West Haven, CT.
- Hall-Craggs M, Light PD, Peters RW "Development of immune complex nephritis during treatment with the calcium channel-blocking agent nifedipine." Hum Pathol 15 (1984): 691-4
Nifedical XL
非专利名称: nifedipine
品牌: Adalat CC, Afeditab CR, Nifediac CC, Nifedical XL, Procardia, Procardia XL, Adalat
同义词: Nifedical XL (Oral)
公认药物相互作用的清单
DiseDoc 和平
与食物,生活方式相互作用
药物互相作用